Cardio Diagnostics Holdings, Inc. (CDIO)
1.69
-0.06
(-3.43%)
USD |
NASDAQ |
Oct 30, 16:00
1.69
0.00 (0.00%)
After-Hours: 17:21
Cardio Diagnostics Holdings Enterprise Value : -0.0379M for Oct. 29, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 29, 2026 | -0.0379M |
| October 28, 2026 | -0.1859M |
| October 27, 2026 | -0.1859M |
| October 26, 2026 | -0.1267M |
| October 23, 2026 | -0.2154M |
| October 22, 2026 | -0.1711M |
| October 21, 2026 | 0.0213M |
| October 20, 2026 | -0.1267M |
| October 19, 2026 | -0.3634M |
| October 16, 2026 | -0.2154M |
| October 15, 2026 | -0.0083M |
| October 14, 2026 | -0.2746M |
| October 13, 2026 | -0.0379M |
| October 12, 2026 | 0.0509M |
| October 09, 2026 | 0.3173M |
| October 08, 2026 | 0.2877M |
| October 07, 2026 | 0.5836M |
| October 06, 2026 | 0.702M |
| October 05, 2026 | 0.8796M |
| October 02, 2026 | 0.5836M |
| October 01, 2026 | 0.4652M |
| September 30, 2026 | 0.406M |
| September 29, 2026 | 0.3173M |
| September 28, 2026 | 0.3877M |
| September 25, 2026 | 0.554M |
| Date | Value |
|---|---|
| September 24, 2026 | 0.4356M |
| September 23, 2026 | 0.4652M |
| September 22, 2026 | 0.4652M |
| September 21, 2026 | 0.4652M |
| September 18, 2026 | 0.7612M |
| September 17, 2026 | 0.7908M |
| September 16, 2026 | 0.702M |
| September 15, 2026 | 0.702M |
| September 14, 2026 | 0.9092M |
| September 11, 2026 | 0.7908M |
| September 10, 2026 | 0.6428M |
| September 09, 2026 | 0.9092M |
| September 08, 2026 | 0.5836M |
| September 04, 2026 | 0.2877M |
| September 03, 2026 | 0.1989M |
| September 02, 2026 | 0.2285M |
| September 01, 2026 | 0.2581M |
| August 31, 2026 | 0.3173M |
| August 28, 2026 | 0.2581M |
| August 27, 2026 | 0.3173M |
| August 26, 2026 | 0.4948M |
| August 25, 2026 | 0.4356M |
| August 24, 2026 | 0.48M |
| August 21, 2026 | 0.7908M |
| August 20, 2026 | 1.324M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Tenax Therapeutics, Inc. | -58.55M |
| Exicure, Inc. | 4.241M |
| Century Therapeutics, Inc. | 182.55M |
| Absci Corp. | 1.879B |
| Celularity, Inc. | 94.12M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.502M |
| Revenue (Quarterly) | 0.0054M |
| Total Expenses (Quarterly) | 1.507M |
| EPS Diluted (Quarterly) | -0.5073 |
| Gross Profit Margin (Quarterly) | -824.1% |
| Profit Margin (Quarterly) | -27.81K% |
| Earnings Yield | -172.5% |
| Normalized Earnings Yield | -172.46 |